REQUEST A DEMO
Total
USD $0.00
Search more companies

Pyxus Pharmaceuticals Private Limited (India)

Main Activities: Other Business Support Services
Full name: Pyxus Pharmaceuticals Private Limited Profile Updated: September 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Pyxus Pharmaceuticals Private Limited is an unlisted company, incorporated on 08/08/2018. It has its registered office in the State of Gujarat, India. Company's corporate identification number (CIN) is U74999GJ2018PTC103565 and registration number is 103565. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
A/707, Mondeal Heights, Beside Novotel Hotel, Nr. Iscon Square, S.G. Highway
Ahmedabad; Gujarat; Postal Code: 380015

Contact Details: Purchase the Pyxus Pharmaceuticals Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Pyxus Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Pyxus Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
August 08, 2018
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Subsidiaries
Shiner Life Sciences Private Limited
20%
Company Performance
Financial values in the chart are available after Pyxus Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-23.4%
Total operating revenue
-24.45%
Operating profit (EBIT)
59.48%
EBITDA
43.96%
Net Profit (Loss) for the Period
65.15%
Total assets
37.91%
Total equity
31.12%
Operating Profit Margin (ROS)
2.77%
Net Profit Margin
2.12%
Return on Equity (ROE)
4.89%
Quick Ratio
0.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?